Dermata Therapeutics, Inc. (NasdaqCM: DRMA)
Health Care · Biotechnology · US
$0.86
-15.69% today · -79.5% 1Y
Dermata Therapeutics, Inc. (NasdaqCM: DRMA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $3.46M and employs 9 people.
Over the last twelve months the share price has lost 79.5%, trading between 0.60 and 4.66.
Tweenvest scores Dermata Therapeutics, Inc. across four factors: quality 35/100, value 68/100. Its strongest factor is value.
DRMA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.46M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -3.33
- Dividend yield
- —
- Beta (5Y)
- 0.66
- 52-week high
- $4.66
- 52-week low
- $0.60
- Avg volume (3M)
- —
- Shares outstanding
- 4.02M
- Employees
- 9
- Next earnings
- —
About Dermata Therapeutics, Inc.
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
- ISIN
- US2498455045
- Founded
- 2014
- Listed since
- Aug 13, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| KALA BIO, Inc.NasdaqCM: KALA | $3.67M | $0.19 | -35.40% |
| PharmaCyte Biotech, Inc.NasdaqCM: PMCB | $3.65M | $0.34 | -15.88% |
| StageZero Life Sciences Ltd.TSXV: SZLS.H | $3.64M | CA$— | — |
| Tissue Repair LtdASX: TRP | $3.56M | AU$0.09 | -5.56% |
| Lunai Bioworks Inc.NasdaqCM: LNAI | $3.43M | $0.68 | -44.68% |
| Ernexa Therapeutics Inc.NasdaqCM: ERNA | $3.41M | $2.09 | -12.92% |
| National Graphite Corp.OTCPK: NGRC | $3.41M | $0.02 | +5.24% |
| Chosa Oncology ABNGM: CHOSA | $3.31M | Skr— | — |
Figures last refreshed Oct 18, 2026.